Sclerotherapy for treatment of hemangiomas

Dermatol Surg. 2000 Feb;26(2):105-8. doi: 10.1046/j.1524-4725.2000.98012.x.


Background: While sclerotherapy in chronic venous insufficiency and in hemorrhoids is well established, the use of sclerotherapy for hemangiomas of the skin is widely unknown.

Objective: The aim of the study was to analyze the clinical value of sclerotherapy with polidocanol in a larger population.

Methods: Over a period of 20 years (1975-1995) we performed sclerotherapy of hemangiomas and vascular malformations in a total of 157 patients. Their ages ranged from 3 months to 75 years. Among these were 87 (55.4%) children and adolescents (up to the age of 18). Sclerotherapy with polidocanol was carried out mostly at monstrous or rapidly growing cavernous hemangiomas mainly localized in the face.

Results: One to three injections was usually sufficient to obtain the sclerosis effect; aesthetically, long-term results were convincing. Severe complications were not observed.

Conclusion: Sclerotherapy of hemangiomas is a relatively simple, effective, and inexpensive method that is a valuable and promising treatment.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Female
  • Follow-Up Studies
  • Hemangioma / therapy*
  • Humans
  • Infant
  • Male
  • Polidocanol
  • Polyethylene Glycols / administration & dosage
  • Sclerosing Solutions / administration & dosage
  • Sclerotherapy / methods*
  • Sclerotherapy / statistics & numerical data
  • Skin Neoplasms / therapy*
  • Treatment Outcome


  • Sclerosing Solutions
  • Polidocanol
  • Polyethylene Glycols